BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15371946)

  • 41. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ovarian epithelial tumors of borderline malignancy in Japan.
    Nakashima N; Nagasaka T; Oiwa N; Nara Y; Fukata S; Fukatsu T; Takeuchi J
    Gynecol Oncol; 1990 Jul; 38(1):90-8. PubMed ID: 2162318
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary ovarian mucinous adenocarcinoma of intestinal type: a clinicopathologic study of 46 cases.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Siriaunkgul S
    Int J Gynecol Pathol; 2014 Mar; 33(2):176-85. PubMed ID: 24487473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intestinal type and endocervical-like ovarian mucinous neoplasms are immunophenotypically distinct entities.
    Lin X; Lindner JL; Silverman JF; Liu Y
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):453-8. PubMed ID: 18665037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Noninvasive, microinvasive, and invasive mucinous carcinomas of the ovary: a clinicopathologic analysis of 40 cases.
    Nomura K; Aizawa S
    Cancer; 2000 Oct; 89(7):1541-6. PubMed ID: 11013369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal.
    Prat J
    Adv Anat Pathol; 1999 Sep; 6(5):247-74. PubMed ID: 10472378
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Borderline epithelial tumors of the ovary.
    Hart WR
    Mod Pathol; 2005 Feb; 18 Suppl 2():S33-50. PubMed ID: 15761465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].
    Zeng SY; Zhong ML; Liang MR; Li L; Jiang W; Yu XH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):602-6. PubMed ID: 24199926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coexistent endocervical adenocarcinoma and mucinous adenocarcinoma of ovary: a clinicopathologic study of four cases.
    LiVolsi VA; Merino MJ; Schwartz PE
    Int J Gynecol Pathol; 1983; 1(4):391-402. PubMed ID: 6309685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.
    Adsay NV; Conlon KC; Zee SY; Brennan MF; Klimstra DS
    Cancer; 2002 Jan; 94(1):62-77. PubMed ID: 11815961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proliferating (LMP) mucinous tumors of the ovaries with microinvasion: morphologic assessment of 13 cases.
    Khunamornpong S; Russell P; Dalrymple JC
    Int J Gynecol Pathol; 1999 Jul; 18(3):238-46. PubMed ID: 12090592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Serous and mucinous epithelial ovarian tumors--a clinicopathologic study of 116 cases].
    Giurgea NL; Pitrop M; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):389-94. PubMed ID: 23077925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical characteristics and prognosis of mucinous tumors of the ovary.
    Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
    Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A patient with a noninvasive mucinous ovarian borderline tumor presenting with late pleural metastases.
    Simons M; Nagtegaal ID; Overbeek LI; Flucke U; Massuger LF; Bulten J
    Int J Gynecol Pathol; 2015 Mar; 34(2):143-50. PubMed ID: 25675183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mucinous Ovarian Tumors.
    Mills AM; Shanes ED
    Surg Pathol Clin; 2019 Jun; 12(2):565-585. PubMed ID: 31097115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
    Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
    Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytoplasmic and stromal expression of laminin γ 2 chain correlates with infiltrative invasion in ovarian mucinous neoplasms of gastro-intestinal type.
    Okuma E; Ohishi Y; Oda Y; Aishima S; Kurihara S; Nishimura I; Yasunaga M; Kobayashi H; Wake N; Tsuneyoshi M
    Oncol Rep; 2010 Dec; 24(6):1569-76. PubMed ID: 21042753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers.
    Genestie C; Auguste A; Al Battal M; Scoazec JY; Gouy S; Lacroix L; Morice P; Pautier P; Leary A; Devouassoux-Shisheboran M
    Virchows Arch; 2021 May; 478(5):885-891. PubMed ID: 33009577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
    Elishaev E; Gilks CB; Miller D; Srodon M; Kurman RJ; Ronnett BM
    Am J Surg Pathol; 2005 Mar; 29(3):281-94. PubMed ID: 15725796
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases.
    Tabrizi AD; Kalloger SE; Köbel M; Cipollone J; Roskelley CD; Mehl E; Gilks CB
    Int J Gynecol Pathol; 2010 Mar; 29(2):99-107. PubMed ID: 20173494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.